22.16USD-2.38%Mkt Cap: 985.07M $P/E: —1d ago
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to iden…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap985.07M $
Enterprise Value629.92M $
Revenue (TTM)10.32M $
Gross Profit-72.95M $
Net Income (TTM)-80.61M $
Revenue/Share0.2740 USD
Last Price22.16 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees60
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.76
PEG—
EV/EBITDA-6.21
EV/Revenue61.06
P/S95.49
P/B2.59
EPS (TTM)-2.40
EPS (Forward)-2.06
52W Range
4.11083% of range25.95
52W High25.95 USD
52W Low4.110 USD
Profitability
Gross Margin0.00%
Oper. Margin-915.40%
EBITDA Margin0.00%
Profit Margin-896.11%
ROE-29.63%
ROA-27.33%
Growth
Revenue Growth91.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-81.63M $
CapEx (TTM)719.00K $
FCF Margin-565.51%
FCF Yield-5.92%
Net Debt-379.16M $
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity0.02
Current Ratio24.76
Quick Ratio24.38
Book Value/Sh8.541 USD
Cash/Share8.620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)49.50 USD
Upside (mean)+123.4%
Target Range23.00 USD – 73.00 USD
$23.00+123.4% to mean$73.00
# Analysts8
Ownership
Shares Out.44.45M
Float34.95M
Insiders2.44%
Institutions85.17%
Short Interest
Short Ratio5.7d
Short % Float9.51%
Short % Out.8.42%
Shares Short3.74M
Short (prev mo.)1.79M
Technical
SMA 5019.48 (+13.7%)
SMA 20015.59 (+42.2%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)603.62K
Avg Vol (10d)545.81K
Technical Indicators
RSI (14)51.1
MACD1.0177
MACD Signal1.4375
MACD Hist.-0.4197
BB Upper26.19 USD
BB Middle23.21 USD
BB Lower20.22 USD
BB Width25.71%
ATR (14)1.554 USD
Vol Ratio (20d)0.73x